NCT02211560.

Trial name or title	Investigating a phosphatidylserine based dietary approach for the management of mild cognitive impairment
Methods	RCT
Participants	People with mild cognitive impairment (MCI) aged 65‐85 years
Interventions	Each for 24 months: Arm 1: phosphatidylserine omega‐3 (DHA enriched) Arm 2: placebo cellulose capsules
Outcomes	Primary: selective reminding test (SRT) Secondary: mini mental state examination (MMSE), neurological battery test (NBT), dementia (DSM‐4 criteria), mini sleep questionnaire (MSQ), Hamilton Anxiety rating scale (HAM‐A), safety and adverse events
Starting date	Registered on trials registry: 6 August 2014 Study start date: September 2014 Estimated study completion date: September 2019
Contact information	Nadia Niemerzyanski, nadiaN@enzymotec.com; Yael Richter, yaelr@enzymotec.com
Notes	NCT02211560